Pressure BioSciences, Inc. Reports 2007 Financial Results and Provides Busin...(ABILITIES AND STOCKHOLDERS' EQUITY $725...),Health

Consolidated Statements of Operations

For the Year Ended

December 31,

2007 2006

REVENUE:

PCT Products, services, other $399,787 $210,289

Grant revenue 246,083 -

Total revenue 645,870 210,289

COSTS AND EXPENSES:

Cost of PCT products and services 209,050 165,233

Research and development 2,022,730 1,429,711

Selling and marketing 1,386,519 528,265

General and administrative 2,174,739 2,145,196

Total operating costs and

expenses 5,793,038 4,268,405

Operating loss from continuing

operations (5,147,168) (4,058,116)

OTHER INCOME:

Realized gain on securities available

for sale 2,028,720 517,938

Interest income 286,600 381,713

Total other income 2,315,320 899,651

Loss from continuing operations

before income taxes (2,831,848) (3,158,465)

Income tax benefit from

continuing operations 520,214 745,354

Loss from continuing operations (2,311,634) (2,413,111)

DISCONTINUED OPERATIONS:

Gain on sale of net assets related

to discontinued operations (net of

income tax of $218,060) 1,155,973 -

Net loss
'/>"/>